We are live on ! Find out more
GDRX icon

GoodRx Holdings

155 hedge funds and large institutions have $776M invested in GoodRx Holdings in 2023 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 45 increasing their positions, 45 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

31% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 26

16% more call options, than puts

Call options by funds: $3.79M | Put options by funds: $3.26M

5% more funds holding

Funds holding: 147155 (+8)

5% more capital invested

Capital invested by funds: $739M → $776M (+$37M)

2.8% more ownership

Funds ownership: 161%163.8% (+2.8%)

0% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 45

Holders
155
Holders Change
+8
Holders Change %
+5.44%
% of All Funds
2.46%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
34
Increased
45
Reduced
45
Closed
26
Calls
$3.79M
Puts
$3.26M
Net Calls
+$532K
Net Calls Change
-$961K
Name Holding Trade Value Shares
Change
Change in
Stake
FPM
1
Francisco Partners Management
California
$477M
Vanguard Group
2
Vanguard Group
Pennsylvania
$48.9M +$1.19M +177,961 +2%
SLG
3
Silver Lake Group
California
$19.9M
Renaissance Technologies
4
Renaissance Technologies
New York
$15.4M +$1.6M +240,016 +10%
Ameriprise
5
Ameriprise
Minnesota
$14.8M +$14.4M +2,160,541 +459%
PTC
6
Petrus Trust Company
Texas
$12.4M -$4.69M -704,000 -24%
BlackRock
7
BlackRock
New York
$10.4M -$1.29M -193,196 -9%
Morgan Stanley
8
Morgan Stanley
New York
$9.81M +$2.01M +302,177 +21%
SI
9
SQN Investors
California
$9.35M +$11.1M +1,660,267 New
TCMX
10
Technology Crossover Management X
California
$9.31M
O
11
OrbiMed
New York
$8.98M -$1.29M -193,600 -11%
Fuller & Thaler Asset Management
12
Fuller & Thaler Asset Management
California
$8.87M +$10.5M +1,574,860 New
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$8.36M +$1.72M +258,187 +21%
LCM
14
Lakewood Capital Management
New York
$8.19M +$3.39M +508,407 +54%
RRCP
15
Rip Road Capital Partners
Massachusetts
$7.89M +$2.91M +435,883 +45%
ICM
16
Invenomic Capital Management
Massachusetts
$7.35M +$8.71M +1,306,196 New
Assenagon Asset Management
17
Assenagon Asset Management
Luxembourg
$7.04M +$505K +75,690 +6%
Millennium Management
18
Millennium Management
New York
$6.46M -$6.89M -1,033,108 -47%
SAM
19
Sectoral Asset Management
Quebec, Canada
$5.67M +$6.71M +1,007,000 New
Two Sigma Advisers
20
Two Sigma Advisers
New York
$5.28M -$797K -119,500 -11%
State Street
21
State Street
Massachusetts
$5.22M +$525K +78,698 +9%
Jacobs Levy Equity Management
22
Jacobs Levy Equity Management
New Jersey
$4.76M -$2.42M -362,955 -30%
Geode Capital Management
23
Geode Capital Management
Massachusetts
$4.7M +$418K +62,690 +8%
Connor, Clark & Lunn Investment Management (CC&L)
24
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$4.14M -$561K -84,179 -10%
Manulife (Manufacturers Life Insurance)
25
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4.1M -$1.65K -247 -0%

GDRX Hedge Fund Activity: Q3 2023 in Review

155 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q3 2023, worth a combined $776M — up 5% from $739M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new GDRX positions and 26 closed out — a net gain of 8 holders — while 45 added to existing stakes and 45 trimmed.

The largest buyer was Ameriprise, adding an estimated $14.4M. The largest seller was Millennium Management, cutting an estimated $6.89M.

  • 155 institutional investors held GoodRx Holdings (GDRX) as of Q3 2023, up from 147 in Q2 2023.
  • Funds reported $776M of GoodRx Holdings stock for Q3 2023, up 5% quarter-over-quarter.
  • 34 funds opened new GoodRx Holdings positions in Q3 2023 and 26 closed out, a net change of +8 holders.
  • The largest GoodRx Holdings buyer in Q3 2023 was Ameriprise, an estimated $14.4M added.
  • The largest GoodRx Holdings seller in Q3 2023 was Millennium Management, an estimated $6.89M sold.

Based on aggregated 13F filings for Q3 2023.